rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2002-6-18
|
pubmed:abstractText |
Hydrops fetalis is rarely caused by congenital dyserythropoietic anemia (CDA). We report a patient with hydrops fetalis as a result of severe anemia. This patient needed intrauterine transfusions from 21 weeks of gestation until birth. The hematologic study showed an atypical CDA (hydrops fetalis-associated CDA) characterized by features resembling CDA type II, but negative acidified serum lysis test (HEMPAS negative). The patient was regularly transfused for a year, after which an allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling was successfully carried out. His actual hemoglobin is 127 g/L, and he has not received transfusions for more than a year. In conclusion, intrauterine transfusions and BMT could cure an otherwise lethal atypical CDA.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-4971
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
100
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
356-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12070051-Adult,
pubmed-meshheading:12070051-Anemia, Dyserythropoietic, Congenital,
pubmed-meshheading:12070051-Blood Transfusion, Intrauterine,
pubmed-meshheading:12070051-Bone Marrow Transplantation,
pubmed-meshheading:12070051-Family Health,
pubmed-meshheading:12070051-Female,
pubmed-meshheading:12070051-Fetal Diseases,
pubmed-meshheading:12070051-Humans,
pubmed-meshheading:12070051-Hydrops Fetalis,
pubmed-meshheading:12070051-Infant, Newborn,
pubmed-meshheading:12070051-Male,
pubmed-meshheading:12070051-Pregnancy,
pubmed-meshheading:12070051-Prenatal Diagnosis,
pubmed-meshheading:12070051-Transplantation, Homologous,
pubmed-meshheading:12070051-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation.
|
pubmed:affiliation |
Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Case Reports
|